Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

BACKGROUND: To evaluate if a combination therapy with micropulse diode laser (MPL) shows non-inferiority on visual acuity (BCVA) within 12 months in comparison to standard therapy, i.e. intravitreal injection of ranibizumab alone. SETTING: Institutional. Prospective randomized single-center trial. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Furashova, Olga, Strassburger, Patrick, Becker, Klio Ai, Engelmann, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391612/
https://www.ncbi.nlm.nih.gov/pubmed/32727496
http://dx.doi.org/10.1186/s12886-020-01576-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391612/
https://www.ncbi.nlm.nih.gov/pubmed/32727496
http://dx.doi.org/10.1186/s12886-020-01576-w

Ejemplares similares